CH569732A5 - - Google Patents

Info

Publication number
CH569732A5
CH569732A5 CH450174A CH450174A CH569732A5 CH 569732 A5 CH569732 A5 CH 569732A5 CH 450174 A CH450174 A CH 450174A CH 450174 A CH450174 A CH 450174A CH 569732 A5 CH569732 A5 CH 569732A5
Authority
CH
Switzerland
Application number
CH450174A
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of CH569732A5 publication Critical patent/CH569732A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH450174A 1970-06-05 1971-06-02 CH569732A5 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19702027645 DE2027645A1 (de) 1970-06-05 1970-06-05 Piperazinylalkyl chinazolon (4) den vate, Verfahren zu deren Herstellung und sie enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
CH569732A5 true CH569732A5 (cg-RX-API-DMAC7.html) 1975-11-28

Family

ID=5773104

Family Applications (3)

Application Number Title Priority Date Filing Date
CH802071A CH557829A (de) 1970-06-05 1971-06-02 Verfahren zur herstellung von arylsubstituierten piperazinyl-alkyl- bzw. -alkenyl-chinazolon-(4)-derivaten.
CH450074A CH558374A (de) 1970-06-05 1971-06-02 Verfahren zur herstellung von arylsubstituierten piperazinylalkyl- bezw. alkenyl- chinazolon-(4)-derivaten.
CH450174A CH569732A5 (cg-RX-API-DMAC7.html) 1970-06-05 1971-06-02

Family Applications Before (2)

Application Number Title Priority Date Filing Date
CH802071A CH557829A (de) 1970-06-05 1971-06-02 Verfahren zur herstellung von arylsubstituierten piperazinyl-alkyl- bzw. -alkenyl-chinazolon-(4)-derivaten.
CH450074A CH558374A (de) 1970-06-05 1971-06-02 Verfahren zur herstellung von arylsubstituierten piperazinylalkyl- bezw. alkenyl- chinazolon-(4)-derivaten.

Country Status (10)

Country Link
US (1) US3984555A (cg-RX-API-DMAC7.html)
AT (3) AT318615B (cg-RX-API-DMAC7.html)
BE (1) BE768137A (cg-RX-API-DMAC7.html)
CA (1) CA951319A (cg-RX-API-DMAC7.html)
CH (3) CH557829A (cg-RX-API-DMAC7.html)
DE (1) DE2027645A1 (cg-RX-API-DMAC7.html)
FR (1) FR2100726B1 (cg-RX-API-DMAC7.html)
GB (1) GB1331522A (cg-RX-API-DMAC7.html)
LU (1) LU63267A1 (cg-RX-API-DMAC7.html)
NL (1) NL7107695A (cg-RX-API-DMAC7.html)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4287341A (en) * 1979-11-01 1981-09-01 Pfizer Inc. Alkoxy-substituted-6-chloro-quinazoline-2,4-diones
US6723727B1 (en) * 1996-12-20 2004-04-20 Hoechst Aktiengesellschaft Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them
DE69842109D1 (de) * 1997-08-21 2011-03-10 Shiseido Co Ltd Chinazolin-4-on Derivate, deren Herstellung und deren Verwendung als Haarwuchsmittel oder in äusserlich anzuwendenden Hautpflegemitteln
WO2001025235A1 (en) 1999-10-01 2001-04-12 Advanced Medicine, Inc. Macrocyclic quinazolinones and their use as local anesthetics
SI3029041T1 (sl) * 2000-04-25 2020-08-31 Icos Corporation Inhibitorji humane delta fosfatidil-inozitol 3-kinaze
US6667300B2 (en) 2000-04-25 2003-12-23 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
AUPR201600A0 (en) * 2000-12-11 2001-01-11 Fujisawa Pharmaceutical Co., Ltd. Quinazolinone derivative
CA2459584A1 (en) * 2001-09-05 2003-03-13 Cynthia C. Bamdad Compositions and use thereof in the treatment of cancer
JP2005507876A (ja) 2001-09-05 2005-03-24 ミナーバ バイオテクノロジーズ コーポレイション 癌を治療する組成物および方法
EP1444209A4 (en) * 2001-11-07 2005-02-16 Merck & Co Inc INHIBITORS OF MITOTIC KINESINS
AUPS019702A0 (en) * 2002-01-29 2002-02-21 Fujisawa Pharmaceutical Co., Ltd. Condensed heterocyclic compounds
JP2005536553A (ja) * 2002-08-21 2005-12-02 サイトキネティクス・インコーポレーテッド 化合物、組成物および方法
JP2006512315A (ja) * 2002-11-04 2006-04-13 エヌピーエス ファーマスーティカルズ インコーポレイテッド カルシリティックとしてのキナゾリノン化合物
WO2004111014A1 (en) * 2003-06-06 2004-12-23 Vertex Pharmaceuticals Incorporated Pyrimidine derivatives as modulators of atp-binding cassette transporters
US20050043239A1 (en) * 2003-08-14 2005-02-24 Jason Douangpanya Methods of inhibiting immune responses stimulated by an endogenous factor
US20050054614A1 (en) * 2003-08-14 2005-03-10 Diacovo Thomas G. Methods of inhibiting leukocyte accumulation
WO2005113556A1 (en) 2004-05-13 2005-12-01 Icos Corporation Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
WO2005117889A1 (en) * 2004-05-25 2005-12-15 Icos Corporation Methods for treating and/or preventing aberrant proliferation of hematopoietic
US20080287469A1 (en) * 2005-02-17 2008-11-20 Diacovo Thomas G Phosphoinositide 3-Kinase Inhibitors for Inhibiting Leukocyte Accumulation
US8349850B2 (en) * 2006-03-28 2013-01-08 Atir Holding S.A. Heterocyclic compounds and uses thereof in the treatment of sexual disorders
US9492449B2 (en) 2008-11-13 2016-11-15 Gilead Calistoga Llc Therapies for hematologic malignancies
EP2355828B1 (en) 2008-11-13 2018-05-30 Gilead Calistoga LLC Therapies for hematologic malignancies
EP2411391A1 (en) 2009-03-24 2012-02-01 Gilead Calistoga LLC Atropisomers of2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
CA2759724A1 (en) * 2009-04-20 2010-10-28 Calistoga Pharmaceuticals, Inc. Methods of treatment for solid tumors
US8691829B2 (en) 2009-07-21 2014-04-08 Gilead Calistoga Llc Treatment of liver disorders with PI3K inhibitors
BRPI1003506B1 (pt) 2010-09-24 2019-12-03 Ache Int Bvi Ltd composto alquil-piperazino-fenil-4(3h)quinazolinonas e uso do composto alquil-piperazino-fenil-4(3h)quinazolinonas associado aos receptores serotoninérgicos 5-ht1a e 5-ht2a
EP3581567A1 (en) * 2011-04-10 2019-12-18 Atir Holding S.A. Heterocyclic compounds and uses thereof in the treatment of sexual disorders
EA201691327A1 (ru) 2012-03-05 2017-03-31 Джилид Калистога Ллс Полиморфные формы (s)-2-(1-(9h-пурин-6-иламино)пропил)-5-фтор-3-фенилхиназолин-4(3h)-она
IN2015MN00002A (cg-RX-API-DMAC7.html) 2012-07-09 2015-10-16 Lupin Ltd
KR20160095161A (ko) 2013-12-20 2016-08-10 길리아드 칼리스토가 엘엘씨 포스파티딜이노시톨 3-키나제 억제제의 가공 방법
JP2017500319A (ja) 2013-12-20 2017-01-05 ギリアード カリストガ エルエルシー (s)−2−(1−(9h−プリン−6−イルアミノ)プロピル)−5−フルオロ−3−フェニルキナゾリン−4(3h)−オンの塩酸塩の多形形態
AU2015274696B2 (en) 2014-06-13 2018-09-27 Gilead Sciences, Inc. Phosphatidylinositol 3-kinase inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1053063A (cg-RX-API-DMAC7.html) * 1963-05-18

Also Published As

Publication number Publication date
FR2100726A1 (cg-RX-API-DMAC7.html) 1972-03-24
CA951319A (en) 1974-07-16
FR2100726B1 (cg-RX-API-DMAC7.html) 1975-10-10
GB1331522A (en) 1973-09-26
DE2027645A1 (de) 1971-12-09
BE768137A (fr) 1971-12-06
AT318615B (de) 1974-11-11
CH558374A (de) 1975-01-31
AT317899B (de) 1974-09-25
AT318628B (de) 1974-11-11
CH557829A (de) 1975-01-15
LU63267A1 (cg-RX-API-DMAC7.html) 1972-08-23
NL7107695A (cg-RX-API-DMAC7.html) 1971-12-07
US3984555A (en) 1976-10-05

Similar Documents

Publication Publication Date Title
FR2100726B1 (cg-RX-API-DMAC7.html)
AR204384A1 (cg-RX-API-DMAC7.html)
AU3613471A (cg-RX-API-DMAC7.html)
ATA96471A (cg-RX-API-DMAC7.html)
AU1146470A (cg-RX-API-DMAC7.html)
AU1326870A (cg-RX-API-DMAC7.html)
AU1336970A (cg-RX-API-DMAC7.html)
AR195465A1 (cg-RX-API-DMAC7.html)
AU1277070A (cg-RX-API-DMAC7.html)
ATA672271A (cg-RX-API-DMAC7.html)
AU1189670A (cg-RX-API-DMAC7.html)
AU1247570A (cg-RX-API-DMAC7.html)
AU1328670A (cg-RX-API-DMAC7.html)
AU2115870A (cg-RX-API-DMAC7.html)
AU2144270A (cg-RX-API-DMAC7.html)
AU1235770A (cg-RX-API-DMAC7.html)
AU2131570A (cg-RX-API-DMAC7.html)
AU1004470A (cg-RX-API-DMAC7.html)
AU1064870A (cg-RX-API-DMAC7.html)
AU2112570A (cg-RX-API-DMAC7.html)
AU1083170A (cg-RX-API-DMAC7.html)
AU1086670A (cg-RX-API-DMAC7.html)
AU2130770A (cg-RX-API-DMAC7.html)
CH568291A5 (cg-RX-API-DMAC7.html)
CH545845A (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased